0001144204-17-048372.txt : 20170918
0001144204-17-048372.hdr.sgml : 20170918
20170918061436
ACCESSION NUMBER: 0001144204-17-048372
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170915
FILED AS OF DATE: 20170918
DATE AS OF CHANGE: 20170918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHAH JAISIM
CENTRAL INDEX KEY: 0001242133
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36150
FILM NUMBER: 171088946
MAIL ADDRESS:
STREET 1: C/O PROTINE DESIGN LAB
STREET 2: 37481 MARSTEN DR
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sorrento Therapeutics, Inc.
CENTRAL INDEX KEY: 0000850261
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 330344842
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4955 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-203-4100
MAIL ADDRESS:
STREET 1: 4955 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: QUIKBYTE SOFTWARE INC
DATE OF NAME CHANGE: 19920703
4/A
1
v475336_4a.xml
OWNERSHIP DOCUMENT
X0306
4/A
2017-09-15
2017-09-15
0
0000850261
Sorrento Therapeutics, Inc.
SRNE
0001242133
SHAH JAISIM
C/O SORRENTO THERAPEUTICS, INC.
4955 DIRECTORS PLACE
SAN DIEGO
CA
92121
1
0
0
0
Stock Options
1.80
2017-09-15
4
A
0
35000
0.00
A
2027-09-15
Common Stock
35000
35000
D
This amended report on Form 4 is being filed to amend the Form 4 filed by the reporting person on September 15, 2017 to correct the exercise price, which was inadvertently reported as $1.75.
1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the reporting person's continued service on the issuer's board of directors on each such date.
/s/ Henry Ji, Ph.D., as Attorney-in-Fact
2017-09-18